Mitsui Chemicals Dirección

Dirección controles de criterios 3/4

El CEO de Mitsui Chemicals' es Osamu Hashimoto, nombrado en Apr 2020, tiene una permanencia de 5.83 años. posee directamente un 0.018% de las acciones de la empresa, con un valor de ¥147.59M. La antigüedad media del equipo directivo y de la junta directiva es de 2.3 años y 3.3 años, respectivamente.

Información clave

Osamu Hashimoto

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	4.1yrs
Participación del CEO	0.02%
Permanencia media de la dirección	2.3yrs
Promedio de permanencia en la Junta Directiva	3.4yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Osamu Hashimoto en comparación con los beneficios de Mitsui Chemicals?
Fecha	Compensación total	Salario	Ingresos de la empresa
Dec 31 2023	n/a	n/a	JP¥55b
Sep 30 2023	n/a	n/a	JP¥59b
Jun 30 2023	n/a	n/a	JP¥65b
Mar 31 2023	n/a	n/a	JP¥83b
Dec 31 2022	n/a	n/a	JP¥75b
Sep 30 2022	n/a	n/a	JP¥80b
Jun 30 2022	n/a	n/a	JP¥95b
Mar 31 2022	JP¥140m	JP¥71m	JP¥110b
Dec 31 2021	n/a	n/a	JP¥125b
Sep 30 2021	n/a	n/a	JP¥122b
Jun 30 2021	n/a	n/a	JP¥103b
Mar 31 2021	JP¥140m	JP¥71m	JP¥58b

Compensación vs. Mercado: Datos insuficientes para determinar si la compensación total de Osamu es razonable en comparación con empresas de tamaño similar en el mercado JP.

Compensación vs. Ingresos: La compensación de Osamu ha sido consistente con los resultados de la empresa en el último año.

CEO

Osamu Hashimoto (60 yo)

4.1yrs

Permanencia

JP¥140,000,000

Compensación

Mr. Osamu Hashimoto serves as President & Chief Executive Officer of Mitsui Chemicals, Inc. since April 2020. He had been Managing Executive Officer and Business Sector President of Health Care Business Se...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Osamu Hashimoto	President	4.1yrs	JP¥140.00m	0.018% ¥ 147.9m
Hajime Nakajima	CFO, Senior Managing Executive Officer & Director	4.3yrs	sin datos	0.0087% ¥ 73.3m
Tadashi Yoshino	Senior Managing Executive Officer	2.3yrs	sin datos	0.015% ¥ 130.5m
Taro Koike	Director of IR Department - Corporate Communicate Division	no data	sin datos	sin datos
Yoshinori Andou	Senior Managing Executive Officer	2.3yrs	sin datos	0.0099% ¥ 83.9m
Akio Hirahara	Senior Managing Executive Officer & President of ICT Solutions Business Sector	no data	sin datos	sin datos
Yasuhiro Hosomi	Production & Technology Center Executive & Managing Executive Officer	2.3yrs	sin datos	sin datos
Atsushi Komoriya	Managing Executive Officer & President of Mobility Solutions Business Sector	2.3yrs	sin datos	sin datos
Fumio Yoshizumi	Managing Executive Officer and President of Basic & Green Materials Business Sector	6.1yrs	sin datos	sin datos
Hisayoshi Tanaka	Managing Executive Officer and President of Life & Healthcare Solutions Business Sector	4.3yrs	sin datos	sin datos
Kazumasa Izawa	Managing Executive Officer & CSO	2.3yrs	sin datos	sin datos
Masao Sambe	Managing Executive Officer	2.3yrs	sin datos	sin datos

2.3yrs

Permanencia media

61yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 4183 se considera experimentado (2.3 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Osamu Hashimoto	President	5.9yrs	JP¥140.00m	0.018% ¥ 147.9m
Hajime Nakajima	CFO, Senior Managing Executive Officer & Director	3.9yrs	sin datos	0.0087% ¥ 73.3m
Tadashi Yoshino	Senior Managing Executive Officer	2.9yrs	sin datos	0.015% ¥ 130.5m
Yoshinori Andou	Senior Managing Executive Officer	2.3yrs	sin datos	0.0099% ¥ 83.9m
Hiroshi Nishio	Audit & Supervisory Board Member	2.3yrs	sin datos	0.0054% ¥ 45.8m
Yukiko Yoshimaru	Independent Outside Director	4.9yrs	sin datos	0.0013% ¥ 10.6m
Tsutomu Tannowa	Chairman of the Board	11.9yrs	JP¥127.00m	0.038% ¥ 321.5m
Masaharu Kubo	Audit & Supervisory Board Member	4.3yrs	sin datos	0.027% ¥ 230.0m
Yasuko Gotoh	Audit & Supervisory Board Member	1.3yrs	sin datos	sin datos
Katsuyoshi Shinbo	Audit & Supervisory Board Member	6.9yrs	sin datos	sin datos
Akira Mabuchi	Independent Outside Director	2.9yrs	sin datos	0.00089% ¥ 7.5m
Takayoshi Mimura	Independent Outside Director	2.3yrs	sin datos	0.00011% ¥ 928.8k

3.4yrs

Permanencia media

65yo

Promedio de edad

Junta con experiencia: La junta directiva de 4183 se considera experimentada (3.3 años de antigüedad promedio).

Mitsui Chemicals Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

Mitsui Chemicals, Inc., Annual General Meeting, Jun 27, 2023

Less than half of directors are independent

Mitsui Chemicals, Inc., Annual General Meeting, Jun 24, 2022

Less than half of directors are independent

Recent updates

Estimating The Intrinsic Value Of Mitsui Chemicals, Inc. (TSE:4183)

Take Care Before Diving Into The Deep End On Mitsui Chemicals, Inc. (TSE:4183)

Mitsui Chemicals, Inc. to Report Fiscal Year 2024 Results on May 15, 2024

Consensus EPS estimates fall by 10%

Upcoming dividend of JP¥70.00 per share

Mitsui Chemicals (TSE:4183) Takes On Some Risk With Its Use Of Debt

Third quarter 2024 earnings: EPS misses analyst expectations

Japan Investment Corporation, Dai Nippon Printing Co., Ltd. (TSE:7912), and Mitsui Chemicals, Inc. (TSE:4183) entered into a basic transaction agreement to acquire 50.02% stake in Shinko Electric Industries Co., Ltd. (TSE:6967) from Fujitsu Limited (TSE:6702) for ¥285.1 billion.

Japan Investment Corporation, Dai Nippon Printing Co., Ltd. (TSE:7912), and Mitsui Chemicals, Inc. (TSE:4183) entered into a basic transaction agreement to acquire 50.02% stake in Shinko Electric Industries Co., Ltd. (TSE:6967) from Fujitsu Limited (TSE:6702) for ¥285.1 billion.

Mitsui Chemicals, Inc. to Report Q3, 2024 Results on Feb 07, 2024

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Upcoming dividend of JP¥70.00 per share at 3.4% yield

Mitsui Chemicals, Inc. to Report Q2, 2024 Results on Nov 08, 2023

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Now 21% undervalued

Now 20% undervalued

Mitsui Chemicals, Inc. to Report Q1, 2024 Results on Aug 04, 2023

Full year 2023 earnings: EPS and revenues miss analyst expectations

Mitsui Chemicals, Inc., Annual General Meeting, Jun 27, 2023

Upcoming dividend of JP¥60.00 per share at 3.7% yield

Mitsui Chemicals, Inc. to Report Fiscal Year 2023 Results on May 12, 2023

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Mitsui Chemicals, Inc. to Report Fiscal Year 2022 Results on Mar 16, 2023

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Less than half of directors are independent

Mitsui Chemicals, Inc. to Report Q3, 2023 Results on Feb 03, 2023

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Mitsui Chemicals, Inc. (TSE:4183) announces an Equity Buyback for 4,000,000 shares, representing 2.07% for ¥10,000 million.

Upcoming dividend of JP¥60.00 per share

Mitsui Chemicals Showcases at FIND-DESIGN FAIR ASIA in Singapore New Glass Film, Posica

Mitsui Chemicals, Inc. to Report Q2, 2023 Results on Nov 08, 2022

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Mitsui Chemicals, Inc. to Report Q1, 2023 Results on Aug 05, 2022

Full year 2022 earnings: EPS exceeds analyst expectations

Mitsui Chemicals, Inc., Annual General Meeting, Jun 24, 2022

Less than half of directors are independent

Upcoming dividend of JP¥65.00 per share

Mitsui Chemicals, Inc. to Report Fiscal Year 2022 Results on May 13, 2022

Third quarter 2022 earnings: EPS exceeds analyst expectations

Mitsui Chemicals, Inc. (TSE:4183) entered into a share transfer agreement to acquire 30% stake in Japan Medical Dynamic Marketing, INC. (TSE:7600) from NGK Spark Plug Co., Ltd. (TSE:5334).

Second quarter 2022 earnings released: EPS JP¥160 (vs JP¥61.38 in 2Q 2021)

Upcoming dividend of JP¥55.00 per share

Mitsui Chemicals, Inc. (TSE:4183) announces an Equity Buyback for 3,500,000 shares, representing 1.79% for ¥10,000 million.

Consensus forecasts updated

First quarter 2022 earnings released: EPS JP¥218 (vs JP¥12.16 loss in 1Q 2021)

Consensus EPS estimates increase to JP¥394

Shofu Inc. (TSE:7979) complete the acquisition of 20% stake in Sun Medical Co.,Ltd. from Mitsui Chemicals, Inc. (TSE:4183).

Full year 2021 earnings released: EPS JP¥298 (vs JP¥195 in FY 2020)

Upcoming dividend of JP¥50.00 per share

Mitsui Chemicals, Inc. to Report Fiscal Year 2021 Results on May 13, 2021

Foshan Nanhai Beautiful Nonwoven Co., Ltd. agreed to acquire Mitsui Chemicals Nonwovens (Tianjin) Co., Ltd. from Mitsui Chemicals, Inc. (TSE:4183).

New 90-day high: JP¥3,440

Revenue beats expectations, earnings disappoint

Third quarter 2021 earnings released: EPS JP¥119 (vs JP¥78.75 in 3Q 2020)

New 90-day high: JP¥3,115

Price target raised to JP¥3,282

New 90-day high: JP¥3,090

Mitsui Chemicals, Inc. to Report Q3, 2021 Results on Feb 09, 2021

Mitsui Chemicals, Inc. (TSE:4183) and Mitsui & Co., Ltd. (TSE:8031) made an offer to acquire remaining 46% stake in Honshu Chemical Industry Co., Ltd. (TSE:4115) for ¥9.7 billion.

Mitsui Chemicals, Inc. to Report Q2, 2021 Results on Nov 11, 2020

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad